PLURISTEM THERAPEUTICS INC (PSTI)
US72940R3003 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to PSTI. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.57. This target is 257% above the current price.
PSTI was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about PSTI.
In the previous month the buy percentage consensus was at a similar level.
PSTI was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-07-20 | Alliance Global Partners | Maintains | Buy |
| 2021-05-04 | Alliance Global Partners | Initiate | Buy |